Insulin Inhaler Shows Promise for Type 1 Diabetes
A groundbreaking insulin inhaler could soon spare millions of Type 1 diabetes patients from daily injections. The medical breakthrough offers new hope for easier diabetes management.
Find uplifting stories about heroes, innovations, and solutions
15614 results for "type 1 diabetes"
A groundbreaking insulin inhaler could soon spare millions of Type 1 diabetes patients from daily injections. The medical breakthrough offers new hope for easier diabetes management.

A cheap diabetes drug that's been around for 100 years is helping people with type 1 diabetes use significantly less insulin each day. Scientists are now racing to understand why it works so they can help even more patients.

Australia just approved the first new type 1 diabetes therapy since insulin was discovered over a century ago. The treatment can delay disease progression by an average of two years, giving families precious time before daily insulin begins.

A groundbreaking clinical trial has freed all 12 Type 1 diabetes patients from daily insulin injections, with most achieving normal blood sugar in just 60 days. The combination of transplanted islet cells and a new drug called Tegoprubart could transform life for millions.

Scientists at the University of Chicago have developed a breakthrough nanoparticle system that delivers protective mRNA to insulin-producing cells, potentially preventing type 1 diabetes before it starts. The treatment worked in both mouse and human cells, offering hope for the 1.6 million Americans living with this autoimmune disease.

Stanford Medicine researchers reversed Type 1 diabetes in mice using a groundbreaking dual transplant that resets the immune system. The animals stayed diabetes-free for six months without insulin or immune suppressing drugs.

A groundbreaking UK screening program is catching type 1 diabetes in children before it becomes an emergency, preventing potentially fatal hospital crises. More than 37,000 families have already joined the effort that's transforming childhood diabetes care.

Scientists at the University of Chicago have developed tiny particles that teach insulin-producing cells to protect themselves from autoimmune attack. The breakthrough could delay or prevent type 1 diabetes without suppressing the entire immune system.

Rain couldn't stop 400 Winnipeggers from walking to fund Type 1 diabetes research, smashing their $72,000 goal. Families walked together to prove that no one fights this disease alone.

Groundbreaking therapies combining stem cells and immune drugs are showing real promise in helping people with type 1 diabetes produce their own insulin again. One patient has already delayed disease progression for nearly a decade.

University of Chicago scientists developed a breakthrough mRNA therapy that protects insulin-producing cells from immune attacks, potentially preventing type 1 diabetes before it starts. Early tests in animals show the treatment successfully shields the cells that the disease destroys.

Researchers discovered a cellular clue that could help doctors spot type 1 diabetes before it fully develops. The breakthrough offers hope for catching and potentially stopping the disease earlier than ever before.

Australia has approved Tzield, the first therapy in over 100 years that can delay the onset of type 1 diabetes by an average of two years. The breakthrough gives families precious time before the daily burden of insulin therapy begins.

Scientists at Stanford Medicine eliminated Type 1 diabetes in mice for six months without insulin shots or immune-suppressing drugs. The breakthrough uses an "immune system reset" that could transform treatment for millions living with autoimmune diseases.

A groundbreaking treatment can now delay type 1 diabetes for up to three years, giving families precious time before symptoms begin. The NHS has approved the first-ever drug that stops the disease in its tracks during early stages.

Two children at BC Children's Hospital became the first in Canada to receive a treatment that can delay type 1 diabetes by about two years. This marks a historic shift from just managing the disease to actually changing its course.
Australia just approved the first treatment in 100 years that can delay type 1 diabetes before symptoms even appear. Teplizumab gives families precious extra time without insulin therapy, fear, and constant medical monitoring.

Researchers at CU Anschutz discovered what triggers the autoimmune attack in type 1 diabetes and are now developing ways to stop it. The breakthrough could lead to therapies that delay or prevent the disease affecting 9.5 million people worldwide.

A groundbreaking FDA-approved treatment is helping Type 1 diabetes patients stop daily insulin injections by replacing their destroyed cells with healthy ones from donated organs. University Hospitals in Cleveland is now offering the therapy that freed 70% of trial participants from insulin after just one year.

Researchers have cured type 1 diabetes in mice using a breakthrough method that doesn't require lifelong immune-suppressing medications. The innovative technique creates a blended immune system that accepts transplanted insulin-producing cells naturally.
Showing 20 of 15614